🟢 20/20 Biolabs is trading 5% up today; catalyst unclear

20/20 Biolabs is trading 5.09% up now at $0.50, with no clear catalyst identified.

• The move reverses September 15’s 8.59% decline and September 14’s 7.05% drop.
• No new company announcement or filing clearly explains the September 16 move.
• Investors are monitoring the reconvened shareholder vote on the proposed charter amendment, scheduled for September 16 after insufficient votes at the original meeting; broader biotech weakness does not explain the gain.